Shares of ResMed Inc. RMD slipped 0.26% to $249.33 Wednesday, on what proved to be an all-around rough trading session for ...

ResMed Inc. is downgraded from buy to watchful hold due to valuation concerns, despite strong financial performance and ...

Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh (AU:RMD) has released an update. Jan De Witte, a ...

Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh (AU:RMD) has released an update.Don't Miss our Black Friday ...

Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh (AU:RMD) has released an update. Desney Tan, a ...

Shares of ResMed Inc. RMD inched 0.17% higher to $249.99 Tuesday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index SPX rising 0.57% to 6,021.63 ...

Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh (AU:RMD) has released an update. Unlock your investing potential with TipRanks Premium - Now At 40% OFF! Make smarter ...

Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh (AU:RMD) has released an update. Unlock your investing potential with TipRanks Premium - Now At 40% OFF! Make smarter ...

ResMed Inc. (NYSE: RMD, ASX: RMD) today announced results for its quarter ended September 30, 2024. Revenue increased by 11% to $1.2 billion; up 11% on a constant currency basis Gross margin ...

ResMed, Inc. engages in providing digital health and cloud-connected medical devices. Its digital health technologies and cloud-connected medical devices transform care for people with sleep apnea ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...